REATA PHARMACEUTICALS INC

CUSIP: 75615P103 Class: Common Stock

Cormorant Asset Management, LP's Holding History (CIK: 0001583977)

Note: Option positions (PUT/CALL) are excluded.

Q3 2021
Shares 100,000 Value ($000) $10,061 Avg Close — Range —
Q2 2021
Shares 168,150 Value ($000) $23,798 Avg Close — Range —
Q1 2021
Shares 400,000 Value ($000) $39,880 Avg Close — Range —
Q4 2020
Shares 500,000 Value ($000) $61,810 Avg Close — Range —
Q3 2020
Shares 450,000 Value ($000) $43,839 Avg Close — Range —
Q2 2020
Shares 400,000 Value ($000) $62,408 Avg Close — Range —
Q1 2020
Shares 487,206 Value ($000) $70,323 Avg Close — Range —
Q4 2019
Shares 816,400 Value ($000) $166,897 Avg Close — Range —
Q3 2019
Shares 819,769 Value ($000) $65,819 Avg Close — Range —
Q2 2019
Shares 806,150 Value ($000) $76,060 Avg Close — Range —
Q1 2019
Shares 615,000 Value ($000) $52,564 Avg Close — Range —
Q4 2018
Shares 674,251 Value ($000) $37,825 Avg Close — Range —
Q3 2018
Shares 660,000 Value ($000) $53,962 Avg Close — Range —
Q2 2018
Shares 450,000 Value ($000) $15,737 Avg Close — Range —
Q1 2018
Shares 450,000 Value ($000) $9,230 Avg Close — Range —
Q4 2017
Shares 200,000 Value ($000) $5,664 Avg Close — Range —
Q3 2017
Shares 388,574 Value ($000) $12,085 Avg Close — Range —